We offer an extensive range of assays in human genitourinary tissues including uterus, bladder, prostate, ureter and urethra. Our scientists can estimate the therapeutic efficacy of potential new therapies or assess the likelihood of off-target effects in these tissues.
Diagram of the organ bath model used for our Genitourinary studies.
On the REPROCELL blog
Latest in Drug Discovery
Redefining Success in IBD Drug Discovery with Human Tissue Models
Redefining IBD drug discovery with a dual-pronged approach through human bioengineered and fresh tissue.
11 December 2024
Key Strategies Central Labs Use to Fast-Track Time to Market
Learn how central labs use automation, outsourcing, and AI to accelerate drug development, reduce costs, and improve clinical trial accuracy and efficiency.
18 November 2024
REPROCELL's Advanced Skin Tissue Engineering
Discover REPROCELL's pioneering 3D skin tissue engineering, enhancing drug development and skincare research with accurate and robust human skin models.
31 October 2024
Discover the differentiation potential of induced pluripotent stem cells (iPSC) to cytotoxic NK cells, including recent advancements in research and therapy.
16 October 2024
The Power of Human Tissue Models in Preclinical Research
Discover how human tissue models are transforming drug safety assessments and improving outcomes in preclinical research through real-world case studies.
03 October 2024
